CD20 binding molecules

Details for Australian Patent Application No. 2004240659 (hide)

Owner Applied Molecular Evolution, Inc.

Inventors Allan, Barrett W.; Davies, Julian; Marquis, David M.; Ondek, Brian; Watkins, Jeffry D.

Agent Spruson & Ferguson

Pub. Number AU-B-2004240659

PCT Pub. Number WO2004/103404

Priority 10/849,615 20.05.04 US; 60/471,958 20.05.03 US

Filing date 20 May 2004

Wipo publication date 2 December 2004

Acceptance publication date 28 July 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

17 November 2005 PCT application entered the National Phase

  PCT publication WO2004/103404 Priority application(s): WO2004/103404

15 December 2005 Amendment Made

  The nature of the amendment is: Amend the name of the applicant/patentee Applied Molecular Evolution to Applied Molecular Evolution, Inc.

28 July 2011 Application Accepted

  Published as AU-B-2004240659

24 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004240663-Respiratory control by means of neuroelectrical coded signals

2004240658-Antibiotic composition